Clinical Trial Update: Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pulsatile intravenous insulin therapy for cardiac disease in patients with diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus with Complications

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Diabetes Mellitus, With Complications | Phase 3 | Status: WITHDRAWN